gc012f
gracell
['gc012f ', '$grcl']
3. $grcl +16.3% (2.8x avg. vol), up 93% since may 1. data from gc012f (autologous car-t) at #asco2023, 93.1% orr (27/29), all 29 patients achieved mrd negativity, median pfs of 38 months. $241 mil. mcap, $186 mil. in cash, funded into 2h 24. med. price target $12.57 (+253%) 
Biotech stock analyst. Editor of Biotech Millionaire at Mauldin Economics. Tweets and opinions are not investment advice.